Atlas Trials

PET Imaging Targeting Granzyme B Predicts Immunotherapy Efficacy in Diffuse Large B-cell Lymphoma

Clinical trial NCT06755775 · RECRUITING

Trial details

NCT number
NCT06755775
Sponsor
Ruijin Hospital
Status
RECRUITING
Study type
OBSERVATIONAL
Diffuse Large B-Cell Lymphoma
Start date
2024-07-23
Primary completion
2029-07-23
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.